8-KLeadership Changes

ABBOTT LABORATORIES 8-K Report, Executive Changes (May 1, 2024)

Filed May 1, 2024For Securities:ABT

Summary

Abbott Laboratories (ABT) announced the upcoming retirement of its Executive Vice President, Finance, Robert E. Funck, Jr., effective July 1, 2024. Mr. Funck's departure follows a distinguished 36-year career with the company. This transition marks the end of an era for a key financial executive, and investors will be keen to understand the succession plan and the impact on the company's financial leadership and strategy moving forward.

Key Highlights

  • 1Retirement of Robert E. Funck, Jr., Executive Vice President, Finance, effective July 1, 2024.
  • 2Mr. Funck has served Abbott Laboratories for 36 years.
  • 3The event date for this change was April 25, 2024.
  • 4The filing was made on April 30, 2024, with an event date of April 26, 2024 for the officer notification.
  • 5This filing falls under Item 5.02 of Form 8-K, concerning director and officer changes.
  • 6Philip P. Boudreau, Senior Vice President, Finance and Chief Financial Officer, signed the filing.

Frequently Asked Questions